Congo Starts Ebola Treatment Trial As Cases Reach 1,427, Deaths Hit 440

Congo Starts Ebola Treatment Trial As Cases Reach 1,427, Deaths Hit 440

Credit: iStock/Canva

Text

Updated Jul 4, 2026 | 12:00 AM IST

SummaryAccording to Dr Tedros Adhanom Ghebreyesus, WHO Director-General, the PARTNERS trial in the DR Congo will evaluate the monoclonal antibody MBP134 and the antiviral drug remdesivir, alone and in combination.

End of Article